BioSpace News Archive

Orchestra BioMed™, Inc., (“Orchestra BioMed” or the “Company”), a biomedical innovation company focused on developing transformative therapeutic products for large unmet clinical needs in procedure-based medicine, presented interim two-year data on its MODERATO II patients treated with BackBeat Cardiac Neuromodulation Therapy™ on May 15th, 2021 at the virtual American College of Cardiology (ACC) Meeting

SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today reported financial results for the first quarter ended on March 31, 2021 and provided an update on recent clinical and corporate developments.

Delic Holdings Inc. (“DELIC” or the “Company”) (CSE: DELC) (OTCQB: DELCF), a psychedelic wellness-focused company, is pleased to announce that its acquisition target, Complex Biotech Discovery Ventures Ltd. (“CBDV”), has closed its previously-announced non-brokered private placement (the “Offering”) of 11,441,189 subscription receipts of CBDV (the “Subscription Receipts”)

Makana Therapeutics, a subsidiary of Recombinetics Inc., a leading gene editing company with platform technology applied to biomedicine and animal agriculture, announced today the appointment of Kurt A. Dasse, Ph.D., to its Board of Directors.

FastLabs, a leading rapid medical testing company, is now offering patients a site in west Miami-Dade at Dolphin Mall, located at 11401 NW 12 Street in Sweetwater.

The Reform ® Modular Pedicle Screw System, first introduced by Precision Spine in April 2016, today reaches a monumental milepost, its 30,000 th modular screw implantation. This historic milestone is most impressive when highlighted by the fact that there have been no reported dissociations to date.

Propanc Biopharma, Inc. announced today published key data in a peer reviewed journal confirming the anti tumor potential of a mixture of two pancreatic proenzymes trypsinogen and chymotrypsinogen

Escient Pharmaceuticals, Inc. , a clinical-stage, industry-leading platform company developing Mas-related G Protein-Coupled Receptor (MRGPR)-targeted drugs to address serious, unserved medical needs across a broad range of therapeutic indications, today announced that Christian Weyer, M.D., M.A.S., has joined the company as President and Chief Medical Officer.

Outset Medical, Inc., a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, has joined Moving Health Home, a coalition of innovative healthcare companies seeking to fundamentally change the way policymakers think about home healthcare.

CURE Pharmaceutical Holding Corp. (OTC: CURR), a vertically integrated drug delivery and product development company, reported its financial results and provided an operational update for the first quarter ended March 31, 2021.